Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.51
0.7519.95%
At close: Jul 16, 5:00 PM EST
$4.32
0.5614.76%
Pre-Market: 4:00 AM EST
Armata Pharmaceuticals Inc Analyst Ratings
ARMPAMEX
Armata Pharmaceuticals Analyst Ratings and Price Targets | AMEX:ARMP | Benzinga
Armata Pharmaceuticals Inc has a consensus price target of $15 based on the ratings of 2 analysts. The high is $15 issued by HC Wainwright & Co. on February 23, 2026. The low is $15 issued by HC Wainwright & Co. on February 23, 2026. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Jones Trading, and HC Wainwright & Co. on February 23, 2026, January 5, 2026, and May 19, 2025, respectively. With an average price target of $13 between HC Wainwright & Co., Jones Trading, and HC Wainwright & Co., there's an implied 201.27% upside for Armata Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Jones Trading
1calculated from analyst ratings
Analyst Ratings for Armata Pharmaceuticals
Loading calendar...
FAQ
What is the target price for Armata Pharmaceuticals (ARMP) stock?
The latest price target for Armata Pharmaceuticals (AMEX:ARMP) was reported by HC Wainwright & Co. on February 23, 2026. The analyst firm set a price target for $15.00 expecting ARMP to rise to within 12 months (a possible 247.62% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Armata Pharmaceuticals (ARMP)?
The latest analyst rating for Armata Pharmaceuticals (AMEX:ARMP) was provided by HC Wainwright & Co., and Armata Pharmaceuticals maintained their buy rating.
When was the last upgrade for Armata Pharmaceuticals (ARMP)?
There is no last upgrade for Armata Pharmaceuticals
When was the last downgrade for Armata Pharmaceuticals (ARMP)?
There is no last downgrade for Armata Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Armata Pharmaceuticals (ARMP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Armata Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Armata Pharmaceuticals was filed on February 23, 2026 so you should expect the next rating to be made available sometime around February 23, 2027.
Is the Analyst Rating Armata Pharmaceuticals (ARMP) correct?
While ratings are subjective and will change, the latest Armata Pharmaceuticals (ARMP) rating was a maintained with a price target of $9.00 to $15.00. The current price Armata Pharmaceuticals (ARMP) is trading at is $4.32, which is out of the analyst’s predicted range.
